Article
12-Gene Signature for Prediction of Chemotherapy Response in Gastric Cancer
2026-01-16
Abstract excerpt
<title>Abstract</title> <p>Background Gastric cancer (GC) remains a major global health burden with high rates of recurrence following standard treatment. Fluoropyrimidine-based chemotherapy constitutes the therapeutic backbone for GC; However, inter-patient heterogeneity in treatment response and recurrence risk limits the effectiveness of uniform management strategies. Robust molecular markers capable of strat...
Topics
Open a Topic to create a Post that cites this publication.
- Bioinformatics and Genomic Networks
- Cancer Immunotherapy and Biomarkers
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Treatments and Studies
- Ferroptosis and cancer prognosis
- Gastric Cancer Management and Outcomes
- Genetic factors in colorectal cancer
- Lung Cancer Treatments and Mutations
Identifiers and source
- Literature Corpus work
- eb56707f-d04a-5b11-80b5-ea005ee8b919
- DOI
- 10.21203/rs.3.rs-8584067/v1
